Malignant benign hematology

Malignant benign hematology is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/RTH2.12170
P932PMC publication ID6332750
P698PubMed publication ID30656271

P2093author name stringMichelle Sholzberg
P2860cites workThe American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopeniaQ28305486
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupQ33381983
Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research NetworkQ35677959
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".Q44550364
Update on the catastrophic antiphospholipid syndrome and the "CAPS Registry".Q45780878
Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.Q45863186
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) RegistryQ45879231
Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patientsQ56907610
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)15-17
P577publication date2019-01-01
P1433published inResearch and Practice in Thrombosis and HaemostasisQ50817799
P1476titleMalignant benign hematology
P478volume3

Search more.